There is a critical need for objective biological measures to inform clinical practice and research in autism. Dr. McPartland will review the state of the science and present work from the Autism Biomarkers Consortium for Clinical Trials to advance biomarkers through FDA qualification. He will present emerging strategies to apply them in individuals with profound autism and to translate them into treatment.
Watch webinar recording:
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Presentation
Presented by
Moderated by